Pharmaceutical services and logistics anchor New Jersey's acquisition activity, with buyers competing hardest around the state's life-sciences corridor and the Port of Newark-Elizabeth.
New Jersey's largest employment sectors, based on BLS state employment data — a proxy for where buyer demand is deepest.
| Sector | Employment |
|---|---|
| Trade, Transportation & Utilities | 891,200 |
| Education & Health Services | 824,300 |
| Professional & Business Services | 699,700 |
| Government | 622,100 |
| Leisure & Hospitality | 402,200 |
Strategic pharma buyers and private equity firms are actively consolidating life-sciences service businesses tied to Johnson & Johnson, Merck, and Bristol Myers Squibb, while logistics consolidators compete for warehousing and distribution businesses near the Port of Newark-Elizabeth. Healthcare systems and professional-services buyers round out the state's active acquirer base.
See valuation ranges and business types for any industry in New Jersey.
It depends on your industry and financials, but New Jersey's pharmaceutical-services and healthcare businesses typically run 6–9x EBITDA, logistics and distribution businesses see 3–5x EBITDA, and professional-services firms typically land in the 1–2.5x revenue range. Get a free valuation for an exact estimate based on your numbers.
Most sales close in 3–6 months from the start of the process, depending on the business, its financial readiness, and how quickly a qualified buyer is identified.
Yes. Buyer sourcing and negotiations are handled discreetly so your employees, customers, and competitors don’t learn your business is for sale until you’re ready to disclose it.
Strategic pharma buyers and private equity firms consolidating life-sciences service businesses tied to Johnson & Johnson, Merck, and Bristol Myers Squibb, and logistics consolidators competing for warehousing and distribution businesses near the Port of Newark-Elizabeth.